Thalapathy Vijay’s Mersal has been one of the biggest releases of 2017. Post its release, the film has been declared one of the highest grossers. While the film opened to mixed reviews, the movie performed phenomenally at the box office, not only in Tamil Nadu but also overseas. After become the third film to cross 1 million mark at the US ( After Kabali and Enthiran) and becoming the third highest grosser in Malaysia, the film went to become the second Tmail movie to cross the Rs 200 crore at the Tamil Nadu box office after, Enthiran. While everyone is busy celebrating the film, a certain leading distributor has called out on the collections of Mersal and stated that there is no proof to prove that these collection reports are authenticate. In an interview with WeTalkies, leading distributor Abirami Ramanathan talked about how numbers are inflated to create a curiosity and buzz aorund the film. In a way, these numbers can’t be authenticated and hence they are shared openly. Also Read: Mersal movie review: Thalapathy Vijay’s enigmatic presence and Atlee’s class direction assures a crackling Diwali
As translated by Hindustan Times, here’s what the distributor had to say – “I have been in this industry since 1976. Back then, we’d appoint people to sell tickets in black for inflated price just to create hype for a movie. When public realize the film’s ticket is being sold for an exorbitant rate, they’d be curious to know what’s there in the film. This is the same tactic that’s being followed even today. When you make people believe a film has earned Rs 200 crore, they don’t want to miss out on a film that’s making so much money. Box-office numbers are being shared openly because nobody can question its authenticity because there’s no proof. As a distributor, I can say that a producer can’t know the earnings of his film till the end of its theatrical run,”
The film stars Thalapathy Vijay, Samantha Ruth Prabhu, Nithya Menen, Kajal Aggarwal in the lead. The movie stars the actor in a triple role. The movie throws light on the corrupt practices in the medical industry.